Identification of a founder mutation in the PRPH2 gene in an isolated Pacific Island population

Minal Patil; Andrea L. Vincent

doi:10.1080/13816810.2026.2651178

March 30, 2026Ophthalmic Genetics

Identification of a founder mutation in the PRPH2 gene in an isolated Pacific Island population

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to identify a founder mutation in the PRPH2 gene linked to inherited retinopathy in a specific population.
Analyzed genetic samples from an isolated Pacific Island population.
Investigated phenotypic variability associated with PRPH2 mutations.
Explored implications for targeted molecular testing.
Identified a specific founder mutation in the PRPH2 gene.
Observed significant phenotypic variability among individuals carrying the mutation.
Suggested the potential for tailored gene-based therapeutic strategies.

Implication

Identification of a founder mutation in the PRPH2 gene, indicating a need for targeted therapeutic strategies in this population.

Abstract

PRPH2-associated inherited retinopathy demonstrated marked phenotypic variability in this cohort. Recognition of a founder genetic variant within a geographically isolated population highlights the importance of targeted molecular testing and may inform the development of tailored gene-based 20 therapeutic strategies.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Patil et al. (2026) studied this question.

synapsesocial.com/papers/69cf58285a333a8214609707 https://doi.org/10.1080/13816810.2026.2651178

View Full Paper

Ask AI

Bookmark

Share

Identification of a founder mutation in the PRPH2 gene in an isolated Pacific Island population

Key Points

Implication

Abstract

Discussion

Cite This Study

Identification of a founder mutation in the PRPH2 gene in an isolated Pacific Island population

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading